Sundar PichaiSundar Pichai earned $164M in 2023

Dr. Charles Wu, a well-educated and experienced leader in the pharmaceutical field, recently served as the CEO of Gyre Therapeutics, Inc. He holds a Bachelor's degree in Polymer Chemistry from the University of Science and Technology of China, and a...

Quick Links
G

Dr. Charles Wu

Ex-CEO of Gyre Therapeutics, Inc.

Education

Bachelor's degree in Polymer Chemistry from University of Science and Technology of China; Doctoral degree in Chemistry from University of Maryland; MBA certificate from Tulane University.

Sector of Economy

Healthcare

Born

January 1, 1960 - 65 years ago

CEO of Gyre Therapeutics, Inc. for

0 years 2 months (Oct 2023 - Jan 2024)

Previous Experience

Chief Technology Officer at Beijing Continent Pharmaceuticals Co., Ltd.; Vice President of Active Pharmaceutical Ingredient division at Zhejiang Huahai Pharmaceutical Co., Ltd.; General Manager at Teva Pharmaceutical & Chemical (Hangzhou) Co., Ltd.

Rivals

Competitors/colleagues of Dr. Charles Wu

Holdings

See how much did Dr. Charles Wu make over time.

Dr. Charles Wu's involvement in Gyre Therapeutics, though brief, was impactful. Appointed CEO in late 2023, he bought no stocks, which highlights a cautious approach to wealth accumulation through company equity. His total compensation was $106,152 in 2023, strictly from...

Loading...

Insider Trading

See recent insider trades of Dr. Charles Wu.

No insider trades found for this CEO.

Compensation History

See how much did Dr. Charles Wu make over time.

In 2023, Dr. Charles Wu's total compensation at Gyre Therapeutics was $106,152. His pay came solely from salary, reflecting a no-bonus policy for executives that year. This was a strategic choice aligning with Gyre's focus on performance and operational stability. No stock options or additional compensations were awarded, a sign that the company prioritized accountability and ensured its executives' earnings were linked directly to company performance. His approach to compensation and leadership was marked by transparency and responsibility, indicative of his long-term vision for the firm. Despite not receiving bonuses or stock options, Dr. Wu's leadership style emphasized stability in turbulent times.

Year

2023

Total Compensation

$106.15K

Salary

$106.15K

Board Justification

The compensation program is designed to attract and retain executive talent necessary for the company's success, with a focus on aligning compensation with performance.

Bonus

$0.00

Board Justification

No bonuses were paid to any NEO in respect of the 2023 performance period.

Other

$0.00

Board Justification

No other compensation was reported for 2023.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock grants were vested in 2023.

Performance Metrics

No specific performance metrics were outlined for the 2023 compensation.

Other Gyre Therapeutics, Inc. CEOs

Here are other CEOs of Gyre Therapeutics, Inc.